Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice

BACKGROUND: Although the efficacy of bevacizumab has been established in patients with metastatic colorectal cancer (mCRC), population-based studies are needed to gain insight into the actual implementation of bevacizumab in daily practice. Since these studies are lacking for patients with metachron...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Razenberg, L. G. E. M., van Gestel, Y. R. B. M., de Hingh, I. H. J. T., Loosveld, O. J. L., Vreugdenhil, G., Beerepoot, L. V., Creemers, G. J., Lemmens, V. E. P. P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4754889/
https://ncbi.nlm.nih.gov/pubmed/26882902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2158-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi